The aging immune system: Primary and secondary alterations of immune reactivity in the elderly

Experimental Gerontology

Volumn 32, Issue 4-5, 1997, Pages 401-413

  Wick, Georg ^a,b   Grubeck Loebenstein, Beatrix ^a  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Aging; Alzheimer's disease; Atherosclerosis; Immune system; Vaccination

Indexed keywords

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CONFERENCE PAPER; HUMAN; IMMUNE SYSTEM; IMMUNOREACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE;

AGING; ALZHEIMER DISEASE; ANTIGENS; ARTERIOSCLEROSIS; CELL AGING; HUMANS; IMMUNE SYSTEM; LIPIDS; LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 0030860733     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(96)00152-0     Document Type: Conference Paper

References (70)

1. AHMED, R. and GRAY, D. Immunological memory and protective immunity: Understanding their relation. Science 272, 54-60, 1996.
2. BECKMAN, I., DIMOPOULOS, K., XAIONING, X., BRADLEY, J., HENSCHKE, P., and AHERN, M. T cell activation in the elderly: Evidence for specific deficiencies in T cell/accessory cell interactions. Mech. Ageing Dev. 51, 265-276, 1990.
3. BEGG, N.T. Immunoprophylaxis at extremes of age. J. Antimicrobial. Chemother. 34, 121-128, 1994.
4. BERCZI, I. and NAGY, E. The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function. In: Hormones and Immunity, Berczi, I. and Kovacs, K. (Editors), pp. 145-171, MTP Press Ltd., Lancaster, 1987.
5. BÖCK, G., HUBER, L.A., WICK, G., and TRAILL, K.N. Use of a FACS III for fluorescence depolarization with DPH. J. Histochem. Cytochem. 37, 1653-1658, 1989.
6. BUCKLEY, R.H. Primary immunodeficiency diseases. In: Fundamental Immunology, Paul, W.E. (Editor), pp. 1353-1374, Raven Press, Ltd., New York, 1993.
7. DE LA FUENTA, M. Changes in the macrophage function with aging. Comp. Biochem. Physiol. A 81, 935-938, 1985.
8. + T cells in centenarians and in long-term T cell cultures: A possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29, 601-609, 1994.
9. FAGIOLO, U., HAUSMAN, P.B., RINNOOY-KAN, E., and WEKSLER, M.E. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23, 2375-2378, 1993.
10. GAMBLE, D.A., SCHWAB, R., WEKSLER, M.E., and SZABO, P. Decreased steady state c-myc mRNA in activated T cell cultures from old humans is caused by a smaller proportion of T cells that transcribe the c-myc gene. J. Immunol. 144, 3569-3573, 1990.
11. GLOBERSON, A., TOMER, Y., and SHOENFELD, Y. Aging, natural autoantibodies and autoimmunity. In: Natural Autoantibodies: Their Physiological Role and Regulatory Significance, Shoenfeld, Y. and Isenberg, D. (Editors), pp. 59-81, CRC Press, Boca Raton, FL, 1993.
12. GOTO, M. and NISHIOKA, K. Age- and sex-related changes of the lymphocyte subsets in healthy individuals: An analysis by two-dimensional flow cytometry. J. Gerontol. 44, M51-M56, 1989.
13. GRIFFIN, W.S., STANLEY, L.C., and WING, C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer' disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615, 1989.
14. GRUBECK-LOEBENSTEIN, B., LECHNER, H., and TRIEB, K. Long-term in vitro growth of human T cell clones: Can postmitotic 'senescent' cell populations be defined? Int. Arch. Allergy Immunol. 104, 232-239, 1994.
15. HUANG, Y.-P., PECHERE, J.-C., MICHEL, M., GAUTHEY, L., LORETO, M., CURRAN, J.A., and MICHEL, J.-P. In vitro T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women. J. Immunol. 148, 715-722, 1992.
16. HUBER, L.A., XU, Q., JÜRGENS, G., BÖCK, G., BÜHLER, E., GEY, K.F., SCHÖNITZER, D., TRAILL, K.N., and WICK, G. Correlation of lymphocyte lipid composition membrane microviscosity and mitogen response in the aged. Eur. J. Immunol. 21, 2761-2765, 1991.
17. JÜRGENS, G., XU, Q., HUBER, L.A., BÖCK, G., HOWANIETZ, H., WICK, G., and TRAILL, K.N. Promotion of lymphocyte growth by the high density lipoproteins (HDL): Physiological significance of the HDL binding site. J. Biol. Chem. 264, 8549-8556, 1989.
18. KOMATSUBARA, S., CINADER, B., and MURAMATSU, S. Functional competence of dendritic cells of ageing C57/BL/6 mice. Scand. J. Immunol. 24, 517-525, 1986.
19. LECHNER, H., AMORT, M., STEGER, M.M., MACZEK, C., and GRUBECK-LOEBENSTEIN, B. Regulation of CD95 (APO-1) expression and the induction of apoptosis in human T cells: Changes in old age. Int. Arch. Allergy Immunol. 110, 238-243, 1996.
20. LIGTHART, G.J., CORBERAND, J.X., FOURNIER, C., GALANAUD, P., HUMANS, W., KENNES, B., MÜLLER-HERMELINK, H.K., and STEINMANN, G.G. Admission criteria for immunogerontological studies in man: The SENIEUR Protocol. Mech. Ageing Dev. 28, 47-55, 1984.
21. LYTE, M. and SHINITZKY, M. A special lipid mixture for membrane fluidization. Biochim. Biophys. Acta 812, 133-138, 1989.
22. McCARRON, M., OSBORNE, Y., STORY, C.J., DEMPSEY, I.L., TURNER, D.R., and MORLEY, A.A. Effect of age on lymphocyte proliferation. Mech. Ageing Dev. 41, 211-218, 1987.
23. MEDA, L., CASSATELLA, M., and SZENDREI, G.I., et al. Activation of microglial cells by β-amyloid protein and Interferon-γ. Nature 374, 647-650, 1995.
24. MILLER, A.E. Selective decline in cellular immune response to varicella-zoster in the elderly. Neurology 30, 582-587, 1980.
25. MILLER, R.A. Aging and immune function: Cellular and biochemical analyses. Exp. Gerontol. 29, 21-35, 1994.
26. NAGEL, J.E., CHOPRA, R.K., CHREST, F.J., McCOY, M.T., SCHNEIDER, E.L., HOLBROOK, N.J., and ADLER, W.H. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. J. Clin. Invest. 81, 1096-1102, 1988.
27. OGRA, P.S., STROBER, W., MESTECKY, J., McGHEE, J.R., LAMMAUD, M.E., and BIENENSTOCK, J. Handbook of Mucosal Immunology, Academic Press, Inc., New York, 1994.
28. PERILLO, N.L., WALFORD, R.L., NEWMAN, M.A., and EFFROS, R.B. Human lymphocytes possess a limited in vitro life span. Exp. Gerontol. 24, 177-187, 1989.
29. PERILLO, N.L., NAEIM, F., WALFORD, R.L., and EFFROS, R.B. In vitro cellular aging in T-lymphocyte cultures: Analysis of DNA content and cell size. Exp. Cell Res. 207, 131-135, 1993.
30. PERKINS, E.H., MASSUCCI, J.M., and GLOVER, P.L. Antigen presentation by peritoneal macrophages from young. adult and old mice. Cell. Immunol. 70, 1-10, 1982.
31. PIERI, C., RECCHIONI, R., MORONI, F., MARCHESELLI, F., and LIPPONI, G. Phytohemagglutinin induced changes of membrane lipid packing, c-myc and c-myb encoded protein expression in human lymphocytes during aging. Mech. Ageing Dev. 64, 177-187, 1992.
32. RAO, K.M., CURRIE, M.S., PADMANABHAN, J., and COHEN, H.J. Age-related alterations in actin cytoskeleton and receptor expression in human leukocytes. J. Gerontol. 47, B37-B44, 1992.
33. REIBNEGGER, G., HUBER, L.A., SCHÖNITZER, D., WERNER, E.R., WACHTER, H., WICK, G., and TRAILL, K.N. Approach to define "normal aging" in man. Immune function, serum lipids, lipoproteins and neopterin levels. Mech. Ageing Dev. 46, 67-82, 1988.
34. RICH, E.A., MINCEK, M.A., ARMITAGE, K.B., DUFFY, E.G., OWEN, D.C., FAYEN, J.D., HOM, D.L., and ELLNER, J.J. Accessory function and properties of monocytes from healthy elderly humans for T lymphocyte responses to mitogen and antigen. Gerontology 39, 93-108, 1993.
35. RIVNAY, B., BERGMAN, S., SHINITZKY, M., and GLOBERSON, A. Correlations between membrane viscosity, serum cholesterol, lymphocyte activation and aging in man. Mech. Ageing Dev. 12, 119-126, 1980.
36. RUBEN, F.L., NAGEL, J., and FIREMAN, P. P 1978 Antitoxin responses in the elderly to tetanus-diphtheria in the (Td) immunizations. Am. J. Epidemiol. 108, 145, 1978.
37. SALMON, M., PILLING, D., BORTHWICK, N.J., VINER, N., JANOSSY, G., BACON, P., and AKBAR, A.N. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24, 892-899, 1994.
38. SAPOLSKY, R.M., KREY, L.C., and McEWEN, R.S. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc. Natl Acad. Sci. USA 81, 6174-6177, 1984.
39. SAPOLSKY, R.M., KREY, L.C., and McEWEN, R.S. The neuroendocrinology of stress and aging: The glucocorticoid cascade hypothesis. Endocr. Rev. 7, 284-301, 1986.
40. SCHETT, G., XU, Q., AMBERGER, A., VAN der ZEE, R., RECHEIS, H., WILLEIT, J., and WICK, G. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J. Clin. Invest. 96, 2569-2577, 1995.
41. SCHMITT, T., STEINER, E., KLINGLER, P., SZTANKAY, A., and GRUBECK-LOEBENSTEIN, B. The production of an amyloidogenic metabolite of the Alzheimer amyloid β precursor protein (APP) in thyroid cells is stimulated by interleukin 1β, but inhibited by interferon y. J. Clin Endocr. Metab. 81, 1666-1669, 1996.
42. SCHWAB, R., HAUSMAN, P.B., RINNOOY-KAN, E., and WEKSLER, M.E. Immunological studies of aging X. Impaired T lymphocytes and normal monocyte response from elderly humans to the mitogenic antibodies OKT3 and Leu4. Immunology 55, 677-684, 1985.
43. SCHWAB, R., PFEFFER, L.M., SZABO, P., GAMBLE, D., SCHNURR, C.M., and WEKSLER, M.E. Defective expression of high affinity IL-2 receptors on activated T cells from aged humans. Int. Immunol. 2, 1989.
44. SHAFFER, L.M., DORITY, M.D., GRUPTA-BAUSAL, R., FREDERICKSON, R.C., YOUNKIN, S.G., and BRUNDEN, K.R. Amyloid β protein removal by neuroglial cells in culture. Neurobiol. Aging 16, 737-745, 1995.
45. SONG, L., KIM, Y.H., CHOPRA, R.K., PROUST, J.J., NAGEL, J.E., NORDIN, A.A., and ADLER, W.H. Age-related effects in T cell activation and proliferation. Exp. Gerontol. 28, 313-321, 1993.
46. SPRECHER, E., BECKER, Y., KRAAL, G., HALL, E., HARRISON, D., and SCHULTZ, L.D. Effect of aging on epidermal DC populations in C57BL/6J mice. J. Invest. Dermatol. 94, 247-253, 1990.
47. STEGER, M.M., MACZEK, C., and GRUBECK-LOEBENSTEIN, B. Morphologically and functionally intact dendritic cells can be derived from the peripheral blood of aged individuals. Clin. Exp. Immunol. 105, 544-551, 1996a.
48. STEGER, M.M., MACZEK, C., BERGER, P., and GRUBECK-LOEBENSTEIN, B. Vaccination against tetanus in the elderly: Do recommended vaccination strategies give sufficient protection? Lancet 348ii, 762, 1996b.
49. STEIN, B.E. Vaccinating elderly people. Protecting from avoidable disease. Drug Aging 5, 242-253, 1994.
50. STULNIG, T., MAIR, A., JAROSCH, E., SCHOBER, M., SCHÖNITZER, D., WICK, G., and HUBER, L.A. Estimation of reference intervals from a SENIEUR Protocol compatible aged population for immunogerontological studies. Mech. Ageing Dev. 68, 105-115, 1993.
51. STULNIG, T., MACZEK, C., BÖCK, G., MAJDIC, O., and WICK, G. Reference intervals for human peripheral blood lymphocyte subpopulations from "healthy" young and aged subjects. Int. Arch. Allergy Immunol. 108, 205-210, 1995a.
52. STULNIG, T., KLOCKER, H., JARWOOD, H.J., JR., JÜRGENS, G., SCHÖNITZER, D., JAROSCH, E., HUBER, L.A., AMBERGER, A., and WICK G. In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging. Arterioscler. Thromb. Vasc. Biol. 15, 872-878, 1995b.
53. TRAILL, K.N., SCHÖNITZER, D., JÜRGENS, G., BÖCK, G., PFEILSCHIFTER, R., HILCHENBACH, M., HOLASEK, A., FÖRSTER, O., and WICK, G. Age-related changes in lymphocyte subset proportions, surface differentiation antigen density and plasma membrane fluidity: Application of the EURAGE SENIEUR Protocol admission criteria. Mech. Ageing Dev. 33, 39-66, 1985.
54. TRAILL, K.N., JÜRGENS, G., BÖCK, G., HUBER, L.A., SCHÖNITZER, D., WIDHALM, K., WINTER, U., and WICK, G. Analysis of fluorescent low density lipoprotein uptake by lymphocytes: Paradoxical increase in the elderly. Mech. Ageing Dev. 40, 261-288, 1987.
55. TRAILL, K.N., HUBER, L.A., WICK, G., and JÜRGENS, G. Lipoprotein interactions with T cells: An update. Immunol. Today 11, 411-417, 1990.
56. TRIEB, K., RANSMAYR, G., SGONC, R., LASSMANN, H., and GRUBECK-LOEBENSTEIN, B. APP peptides stimulate lymphocyte proliferation in normals, but not in patients with Alzheimer's disease. Neurobiol. Aging 17, 541-547, 1996.
57. UTUSYAMA, M., HIROKAWA, K., KURASHIMA, C., FUKAYAMA, M., INAMATSU, T., SUZUKI, K., HASHIMOTO, W., and SATO, K. Differential age-change in the numbers of CD4+CD45RA+ and CD4+CD29+ T-cell subsets in human peripheral blood. Mech. Ageing Dev. 63, 57-68, 1992.
58. VANDENABELE, P. and FIERS, W. Is amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6 mediated acute phase response in the brain? Immunol. Today 12, 217-219, 1991.
59. VAN EDEN, W. and YOUNG, D.B. Stress Proteins in Medicine, Marcel Dekker, New York, 1995.
60. VANGOOL, W., SCHENK, D., and BOLHUIS, P. Concentrations of amyloid-beta protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci. Lett. 172, 1-2, 1994.
61. VASILAKOS, J., CARROLL, R., and EMMERLING, M. Interleukin 1b dissociates β-amyloid precursor protein and β-amyloid peptide secretion. FEBS Lett. 354, 289-292, 1994.
62. VETVICKA, V., TLASKALOVA-HOGENOVA, H., and POSPISIL, M. Impaired antigen presenting function of macrophages from aged mice. Immunol. Invest. 14, 105-114, 1985.
63. WALFORD, R.L., JAWAID, S.W., and NAEIM, F. Evidence for in vitro senescence of T lymphocytes cultured from normal human peripheral blood. Age 4, 67-71, 1987.
64. WICK, G., HUBER, L.A., OFFNER, R., WINTER, U., BÖCK, G., SCHAUENSTEIN, K., JÜRGENS, G., and TRAILL, K.N. Immunodeficiency in old age. In: Current Problems in Dermatology, Hönigsmann, H. (Editor), pp. 120-130, S. Karger AG, Basel, 1989.
65. WICK, G., HUBER, L.A., XU, Q., JAROSCH, E., SCHÖNITZER, D., and JÜRGENS, G. The decline of the immune response during aging: The role of an altered lipid metabolism. Ann. NY Acad. Sci. 621, 277-290, 1991.
66. WICK G., HU, Y., and GRUBER, J. The role of the immunoendocrine interaction via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Trends Endocrinol. Metabol. 3, 141-146, 1992.
67. WICK G., HU, Y., SCHWARZ, S., and KROEMER, G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr. Rev. 14, 539-563, 1993.
68. WICK, G., SCHETT, G., AMBERGER, A., KLEINDIENST, R., and XU, Q. Is atherosclerosis an immunologically mediated disease? Immunol. Today 16, 27-33, 1995.
69. WU, W., PAHLAVANI, M., CHEUNG, H.T., and RICHARDSON, A. The effect of aging on the expression of interleukin 2 messenger ribonucleic acid. Cell. Immunology 100, 224-231, 1986.
70. XU, Q., WILLEIT, J., MAROSI, M., KLEINDIENST, R., OBERHOLLENZER, F., KIECHL, S., STULNIG, T., LUEF, G., and WICK, G. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis. Lancet ii, 255-259, 1993.